Gene Variants Raise Risk of Migraines in African-American Children

FOR IMMEDIATE RELEASE

Thursday, Oct. 11, 2018

Contact: John Ascenzi

Children's Hospital of Philadelphia

(267) 426-6055

[email protected]

Gene Variants Raise Risk of Migraines in African-American Children

-CHOP Researcher: Findings may suggest more effective headache treatments-

Newswise — Philadelphia, Oct. 11, 2018–- Pediatric researchers have discovered common gene variants associated with migraines in African-American children. The research adds to knowledge of genetic influences on childhood migraine and may lead to future precision medicine treatments for African-American children with these intense headaches. 

“Scientists already know that migraines may run in families, and other researchers have discovered multiple genetic links to migraine in European adults,” said study leader Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics at Children’s Hospital of Philadelphia (CHOP). “However, this is the first large-scale genetic study of migraine in children and in African-Americans.”

Hakonarson and colleagues published their study online on Sept. 28, 2018 in the Journal of Medical Genetics. 

The researchers performed genome-wide association studies (GWAS) in separate groups of African-American (AA) and European-American (EA) children from CHOP’s pediatric network. One study compared 380 AA children with migraine to 2,129 ancestry-matched control subjects. Another study compared 599 EA children with migraine to 7327 EA controls. 

The scientists found a novel genetic susceptibility locus on chromosome 5, specifically 5q.33.1, that predisposed AA children to migraine, but was not significant for the EA children. The team then performed a replication study that confirmed this finding in an independent pediatric cohort of 233 AA migraine patients compared to 4038 AA control subjects without migraine. 

Further analysis of the risk locus on chromosome 5 implicated two genes, NMUR2 and GLRA1, both involved in signaling pathways in the central nervous system. The researchers said this finding was consistent with previous GWAS research in adults that pointed to genes involved in neurotransmitter release. 

“This work provides new insights into the genetic basis of childhood migraine,” said Hakonarson. He added, “Our hope is that follow-up research on these signaling pathways may eventually lead to targeted migraine treatments for African-American children.”

The National Institutes of Health (grant HG006830) supported this research. 

Xiao Chang, et al, “Common variants at 5q33.1 in Europeans predispose to migraine in African-American children,” Journal of Medical Genetics, online Sept. 28, 2018. http://doi.org/10.1136/jmedgenet-2018-105359 

About Children’s Hospital of Philadelphia: Children’s Hospital of Philadelphia was founded in 1855 as the nation’s first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children’s Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 546-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu